Project-002

项目-002

• 批准号: 10611943
• 负责人: Randall J Urban
• 金额: $ 56.85万
• 依托单位: UNIVERSITY OF TEXAS MED BR GALVESTON
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-08-18 至 2025-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10611943
• 关键词: Address; Advocacy; Cities; Clinical Research; Clinical and Translational Science Awards; Collaborations; Communication; Communities; Development; Discipline; Education; Ensure; Foundational Skills; Health; Health Priorities; Industry; Leadership; Life Cycle Stages; Longevity; Medicine; Methods; Outcome; Patients; Phase; Policy Maker; Process; Research; Research Design; Research Personnel; Science; Sister; Testing; Texas; Training; Training Programs; Translating; Translational Research; United States National Institutes of Health; austin; community engagement; innovation; interest; meetings; member; multidisciplinary; outreach; patient engagement; programs; translational engagement; translational pipeline

Engaging stakeholders through our outreach, research, and training programs has been the highest priority of our CTSA Hub. These efforts increase the capacity for communication between researchers and stakeholders, allowing us to advance the science of community-engaged translational research and build upon our programs in multidisciplinary team-based science. Since 2008, we have focused on advancing team science by developing, testing, and implementing leadership training for scientific teams, and by supporting Multidisciplinary Translational Teams (MTTs) which bring together investigators from diverse disciplines who are working along the translational spectrum to address priority health issues. Our broad-based stakeholders include our leadership, investigators, patients, clinicians, advocacy groups, community members and organizations, sister CTSA hubs, consumers of translational research and health information, commercial interests, and policymakers. Our long-term objective is to integrate community engagement and team-based science across the spectrum of translational science—in leadership and governance, communications, implementation, research, and dissemination. Engaging patients and communities throughout the translational research lifecycle and process enables us to ensure successful outcomes through patient-focused research design, implementation, and dissemination. In past years, our programming has focused on the Houston-Galveston metroplex and, in conjunction with the Texas Regional CTSA Consortium, the other major cities in the state of Texas, i.e., San Antonio, Dallas, and Austin. In the coming cycle, we will be actively increasing scientific and community collaborations with network partners including NCATs and “ECHO” hubs, as well as other NIH Institutes and Centers, federal agencies, and industry. Our Specific Aims include: Aim 1. Engage internal, external, and interdependent stakeholders at local, regional, and national levels to make clinical research at all phases across the lifespan and translational spectrum more responsive to and effective in meeting societal needs for the advancement of science and medicine. We will do this by: promoting new multi-directional communication strategies to engage stakeholders across the translational spectrum, establishing innovative avenues for translating and disseminating relevant science and health information to stakeholders, and advancing the field of community engagement and at regional and national levels; Aim 2. Promote advances in multidisciplinary team science methods, education, best practices, and dissemination to drive significant advances in clinical and translational research by disseminating our portfolio of Team Science Programs involving foundational skills and leadership training to the CTSA consortium. We will also develop community partners’ and patient constituents’ modules for our TeamMAPPS Project to promote inclusion of community members and patients in the development and management of translational teams.

通过我们的推广，研究和培训计划吸引利益相关者一直是我们的最高优先事项， 我们的CTSA中心这些努力提高了研究人员之间的沟通能力， 利益相关者，使我们能够推进社区参与的转化研究的科学，并建立在 我们在多学科团队为基础的科学方案。自2008年以来，我们专注于推进团队 通过开发，测试和实施科学团队的领导力培训，并通过支持 多学科翻译团队（MTT）汇集了来自不同学科的研究人员， 正在沿着转化的方向努力解决优先的健康问题。我们的基础广泛 利益相关者包括我们的领导层、研究者、患者、临床医生、倡导团体、社区 成员和组织，姐妹CTSA中心，转化研究和健康信息的消费者， 商业利益和政策制定者。我们的长期目标是将社区参与和 以团队为基础的科学跨越了翻译科学的范围--在领导和治理方面， 沟通、实施、研究和传播。让患者和社区参与 在翻译研究的整个生命周期和过程中，使我们能够确保成功的结果 通过以患者为中心的研究设计，实施和传播。在过去的几年里，我们的编程 专注于休斯顿-加尔维斯顿大都市，并与德克萨斯州区域CTSA合作， 财团，在得克萨斯州的其他主要城市，即，圣安东尼奥，达拉斯和奥斯汀。在未来几 周期，我们将积极增加与网络合作伙伴的科学和社区合作，包括 NCAT和“ECHO”中心，以及其他NIH研究所和中心、联邦机构和行业。我们 具体目标包括：目标1。在地方、区域和区域层面， 国家层面，使临床研究在整个生命周期和转化谱的所有阶段， 响应并有效地满足社会对科学和医学进步的需求。我们将尽 促进新的多方向沟通战略， 翻译谱，建立翻译和传播相关科学的创新途径 向利益攸关方提供健康信息，推动社区参与领域和区域 目标2.促进多学科团队科学方法，教育，最佳 实践和传播，以推动临床和转化研究的重大进展， 传播我们的团队科学计划组合，包括基础技能和领导力培训， CTSA财团。我们还将开发社区合作伙伴和患者选民模块， TeamMAPPS项目，以促进社区成员和患者参与发展和 翻译团队的管理。